WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

BlueWind gets a Category I CPT code for subfascial tibial neuromodulation Emboline runs its first US commercial Emboliner cases at Columbia SedMed raises $4M for a toilet lift that runs without power Surmodics buys Alta Biomed for its PzF coating and a Carlsbad blood loop lab FDA names the first five companies in its READI-Home readmissions program CDRH plans 11 final guidances in FY2027 and puts AI lifecycle management first Edwards wins FDA approval for a pulmonary valve that expands from 13 mm to 22 mm Medtronic wins a Category I CPT code for renal denervation, effective January 2028 Axogen closes the BioCircuit deal and puts $34M of 2027 revenue on NerveTape BlueWind gets a Category I CPT code for subfascial tibial neuromodulation Emboline runs its first US commercial Emboliner cases at Columbia SedMed raises $4M for a toilet lift that runs without power Surmodics buys Alta Biomed for its PzF coating and a Carlsbad blood loop lab FDA names the first five companies in its READI-Home readmissions program CDRH plans 11 final guidances in FY2027 and puts AI lifecycle management first Edwards wins FDA approval for a pulmonary valve that expands from 13 mm to 22 mm Medtronic wins a Category I CPT code for renal denervation, effective January 2028 Axogen closes the BioCircuit deal and puts $34M of 2027 revenue on NerveTape

The Directory / Cardiovascular

Cardiovascular

Archimedes Vascular

Birmingham, AL · Series A · In development

Developing Barostent, a catheter-delivered implant placed in the aortic arch to induce the baroreflex. The target is severe hypertension that drugs and renal denervation have not controlled.

← More Cardiovascular startups